Story
IBM, Cleveland Clinic, RIKEN Nominated for Gordon Bell Prize
IBM, Cleveland Clinic, and RIKEN are finalists for the 2026 ACM Gordon Bell Prize for simulating the largest biologically meaningful molecules using quantum-centric supercomputing. This advancement highlights the growing potential of hybrid quantum and classical computing in complex scientific research. The winner will be announced in November.
Investors can monitor 's progress in advanced computing technologies as it contributes to significant scientific breakthroughs. Advances like this highlight the company's commitment to cutting-edge research, potentially influencing its long-term growth trajectory in the technology sector.
